Vibeke K. Parner

Adjuvant <i>nab</i> -Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III Trial

Margaret A. Tempero, Uwe Pelzer, Eileen M. O’Reilly et al. · Journal of Clinical Oncology · 2022 · 120 citations · Full text

LBA-1 Phase 3 APACT trial of adjuvant nab-paclitaxel plus gemcitabine (nab-P + Gem) vs gemcitabine (Gem) alone in patients with resected pancreatic cancer (PC): Updated 5-year overall survival

Margaret A. Tempero, Eileen M. O’Reilly, Eric Van Cutsem et al. · Annals of Oncology · 2021 · 30 citations · Full text

Surgical Oncology, Lba-1 Phase 3, Pancreatic Cancer +8

Clinical outcome of percutaneous RF-ablation of non-operable patients with liver metastasis from breast cancer

Iben Kümler, Vibeke K. Parner, Malgorzata Tuxen et al. · La radiologia medica · 2015 · 20 citations

Percutaneous Rf-ablation, Surgical Oncology, Medicine +8

Capecitabine and Oxaliplatin Before, During, and After Radiotherapy for High-Risk Rectal Cancer

Finn Ole Larsen, Alice Markussen, Benny Vittrup Jensen et al. · Clinical Colorectal Cancer · 2016 · 13 citations

Surgical Oncology, Radiation Therapy, Medicine +8